This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignees: Fuso Pharmaceutical Industries, Ltd., Hokkaido University. Active years: 2020-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2020-2023
Title: Yumiko Kagawa: Innovator in Antibody Development
Introduction
Yumiko Kagawa is a prominent inventor based in Hokkaido, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies for cancer detection. With a total of 2 patents, her work is paving the way for advancements in medical diagnostics.
Latest Patents
Kagawa's latest patents focus on an anti-PD-L1 antibody designed for detecting PD-L1 in tumor cells, such as melanoma cells. The invention includes a light chain with specific amino acid sequences in its complementarity-determining regions (CDRs) and a heavy chain with its own unique sequences. This innovative antibody composition serves as an active ingredient for detecting PD-L1, and a method for preparing the antibody is also provided.
Career Highlights
Throughout her career, Yumiko Kagawa has worked with esteemed institutions, including Hokkaido University and Fuso Pharmaceutical Industries, Ltd. Her research has been instrumental in advancing the understanding of cancer biomarkers and improving diagnostic techniques.
Collaborations
Kagawa has collaborated with notable colleagues such as Satoshi Takagi and Shiro Murata. These partnerships have further enriched her research and contributed to her success in the field.
Conclusion
Yumiko Kagawa's innovative work in antibody development highlights her significant role in the biotechnology sector. Her contributions are essential for the future of cancer diagnostics and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile